Vertical AI
Programmable DNA drug destroying all cancers, unlocking 80% of targets
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
The company was founded by Jeff Liu; Li-Yao Huang; Steven Lin. It is part of YC Spring 2026. It is based in Oxford, England, United Kingdom.
| Fact | Detail |
|---|---|
| Batch / Program | YC Spring 2026 |
| Headquarters | Oxford, England, United Kingdom |
| Industry | Healthcare |
| Category | Vertical AI Startups |
| Founders | Jeff Liu, Li-Yao Huang, Steven Lin |
| Website | finaldose.ai |
Listed in the AIToolGuide 2026 startups database (513 AI companies). Listings are free; no paid offers. Data as recorded from Y Combinator batch listings, November 2026.
